The present invention relates to substituted benzopyran derivatives,
stereoisomers, and pharmaceutical acceptable salts thereof useful as
Estrogen Receptor beta agonists for treating Estrogen Receptor beta
mediated diseases such as benign prostatic hyperplasia.